Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Selecta Biosciences commences clinical trial of vaccine for smoking cessation

Nov. 23, 2011

BioDelivery Sciences begins dose-finding BNX-102 study

Nov. 11, 2011

BARDA awards contract to RxBio to develop radiomitigant countermeasure drug

Nov. 9, 2011

Novel radioprotective agents divulged by Peter MacCallum Cancer Centre

Nov. 7, 2011

NIH grant awarded for AEOL-10150 as medical countermeasure against nerve agents

Oct. 27, 2011

FDA provides update on safety review of Chantix

Oct. 26, 2011

FDA grants accelerated approval to ApoPharma's Ferriprox

Oct. 18, 2011

G-Zero Therapeutics receives NIH grant for studies in radiation exposure

Oct. 5, 2011

Nanotherapeutics receives U.S. government contract to develop oral radiation drug

Oct. 4, 2011

OX-219 shows promise in patients with opioid dependence

Sep. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...